Shorts and bashers don't need much help. CYDY has provided plenty along the way. Competitors don't give a crap. They move ahead while CYDY does little to nothing on its own.

We can hope something comes from others work with leronlimab such as the cancer research or perhaps Dr Saccha.

Has CYDY presented an acceptable go forward plan to the FDA or not? Get this train pulling out of the station!